title: Eplerenone, an aldosterone antagonist, reduces hospitalization and death in heart failure patients with NYHA class II and an ejection fraction of less than 30%.
authors.affiliation: Medicina Interna 2, Ospedale L. Sacco, Università degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, MI, Italy. simone.birocchi@studenti.unimi.it
authors.forename: Simone
authors.initials: S
authors.lastname: Birocchi
authors.forename: Giulia Carla Luisa
authors.initials: GC
authors.lastname: Cernuschi
mesh_terms: D000077545:Eplerenone; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000401:mortality* / Q000503:physiopathology; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013318:Stroke Volume
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone